Looking Ahead: Dermatology Clinical Trial Landscape in 2023
The global market for dermatology drugs is projected to grow at a CAGR of 11.22% from 2022 to 2027 to reach US$47.9 billion by 2027. The primary factors driving growth are the increasing prevalence of dermatological conditions and the rise of R&D in healthcare. Download Vial’s white paper to learn more about the dermatology clinical trial landscape in 2023!
This white paper will cover:
- Growth in the dermatology drug market
- Projections for dermatology treatment spending
- Challenges and opportunities in tele-dermatology